Physician profile
Molly Simpson Singletary
NPI 1407917453
$820.54
in general payments reported to CMS, 2019-2025
10 companies · $107 in 2025
The $107 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.76 · 2020: $11.90 · 2021: $80.60 · 2022: $166 · 2023: $170 · 2024: $201 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $211.44 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $188.13 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Corium, LLC | $146.33 | 2022-2024 | Azstarys |
| Sanofi Pasteur INC. | $62.49 | 2021-2024 | |
| Seqirus USA INC | $61.00 | 2022-2024 | Flucelvax, Flucelvax Quadrivalent |
| Ironshore Pharmaceuticals INC. | $44.81 | 2019-2021 | |
| Tris Pharma INC | $40.00 | 2025 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $34.85 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $18.75 | 2023 | Qelbree |
| Abbvie INC. | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Singletary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.